Other studies also identified novel PDI inhibitors (e.g., juniferdin77, origamicin78, 16F1679, securinine80, P181, and 35G882) to treat HIV-1 infection, neurodegenerative diseases, or glioblastoma. This evidence concerns the gene P4HB and neurodegenerative disease.